Donald L. Hagan LLC Makes New $1.21 Million Investment in Cabot Corporation $CBT

Key Points

• Donald L. Hagan LLC has made a new investment of approximately $1.21 million in Cabot Corporation, acquiring 16,193 shares during the second quarter.
• Cabot Corporation reported a quarterly earnings per share of $1.90, exceeding analysts' expectations, despite a revenue of $923 million falling short of the anticipated $957.29 million.
• The company recently announced a quarterly dividend of $0.45, yielding 2.4%, and has set its FY 2025 guidance for earnings per share between 7.150 and 7.500.

Donald L. Hagan LLC acquired a new position in shares of Cabot Corporation (NYSE:CBT - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,193 shares of the specialty chemicals company's stock, valued at approximately $1,214,000.

Several other large investors have also recently added to or reduced their stakes in CBT. Geneos Wealth Management Inc. grew its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock worth $38,000 after buying an additional 364 shares during the last quarter. Banque Cantonale Vaudoise bought a new stake in shares of Cabot during the first quarter valued at approximately $43,000. CWM LLC grew its stake in shares of Cabot by 55.0% during the first quarter. CWM LLC now owns 600 shares of the specialty chemicals company's stock valued at $50,000 after purchasing an additional 213 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Cabot by 52.4% during the second quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company's stock valued at $55,000 after purchasing an additional 251 shares during the last quarter. Finally, Brooklyn Investment Group grew its stake in shares of Cabot by 1,553.7% during the first quarter. Brooklyn Investment Group now owns 678 shares of the specialty chemicals company's stock valued at $56,000 after purchasing an additional 637 shares during the last quarter. 93.18% of the stock is owned by institutional investors.

Cabot Price Performance

Shares of CBT stock opened at $76.04 on Wednesday. Cabot Corporation has a 52-week low of $70.40 and a 52-week high of $117.46. The stock has a market cap of $4.05 billion, a PE ratio of 9.94 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. The firm's 50 day moving average price is $78.29 and its two-hundred day moving average price is $77.75.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm had revenue of $923.00 million for the quarter, compared to analysts' expectations of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. As a group, analysts forecast that Cabot Corporation will post 7.57 EPS for the current year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 11th. Shareholders of record on Friday, August 29th were issued a $0.45 dividend. The ex-dividend date was Friday, August 29th. This represents a $1.80 annualized dividend and a yield of 2.4%. Cabot's dividend payout ratio (DPR) is 23.53%.

Analyst Upgrades and Downgrades

Separately, UBS Group set a $82.00 price target on shares of Cabot and gave the company a "neutral" rating in a research note on Tuesday, August 5th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $92.33.

Insiders Place Their Bets

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares in the company, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 3.03% of the company's stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.